New Issue: Orbital Catastrophe Ahead? Read Now

Making Evolution Make Microbes Make Products

By selecting for bacteria that can survive only if they make a particular product of interest over multiple iterations, researchers vastly improved yields and decreased production times. Cynthia Graber reports

 

Illustration of a Bohr atom model spinning around the words Science Quickly with various science and medicine related icons around the text

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Genetically engineered bacteria already produce some products of commercial interest or biomedical importance, such as insulin. And coaxing the organisms to do so can be done with a cleaner setup and produce fewer environmentally problematic byproducts than other production methods. But the bacterial approach has stayed limited to just a few products, due to inefficiencies.

Now a research team at Harvard’s Wyss Institute for Biologically Inspired Engineering says they’ve developed a system to get microbes to produce chemicals dramatically faster and more efficiently. The technique uses Darwinian principles over multiple iterations, what they call rounds of evolution. The study is in the Proceedings of the National Academy of Sciences. [Srivatsan Raman et al, Evolution-guided optimization of biosynthetic pathways]

The researchers induced mutations in specific genes related to the expression of the desired molecule. They then tweaked the bacteria so that genes for antibiotic resistance only become active when the cells make some of the sought-after product. With antibiotics present, cells die that do not produce enough of the product. Because those cells also do not have the life-saving resistance to the antibiotics. The surviving cells, however, show promise.

The system takes the cells through this evolutionary cycle repeatedly, eliminating unproductive bacteria each time.

The end result: microbes that synthesize the chemical of interest with 30 times the output of current bacterial compounds production systems, and up to a thousand times faster.

The researchers say their program could work to efficiently produce for a wide variety of useful compounds. Which might make vats of modified bacteria tomorrow’s leaders of commercial chemical manufacturing.

—Cynthia Graber

[The above text is a transcript of this podcast.]
 

Cynthia Graber is a print and radio journalist who covers science, technology, agriculture, and any other stories in the U.S. or abroad that catch her fancy. She's won a number of national awards for her radio documentaries, including the AAAS Kavli Science Journalism Award, and is the co-host of the food science podcast Gastropod. She was a Knight Science Journalism fellow at MIT.

More by Cynthia Graber

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe